Trademark: 88369665
Word
VYNDAMAX
Status Date
Tuesday, November 19, 2019
Registration Number
5916879
Registration Date
Tuesday, November 19, 2019
Filing Date
Wednesday, April 3, 2019
Published for Opposition
Tuesday, June 18, 2019
5 Pharmaceutical preparations for the treatment of a rare protein misfolding disease, namely, amyloidosis; Pharmaceutical preparations for the treatment of cardiovascular diseases and disorders
The mark consists of the word "VYNDAMAX" with three curved lines, each tapering to a point, that form a flare design above and to the right of the letter "X".
Color is not claimed as a feature of the mark.
Mar 27, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Mar 27, 2023
Teas Change Of Correspondence Received
Mar 27, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 27, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 27, 2023
Teas Change Of Owner Address Received
Nov 19, 2019
Registered-Principal Register
Oct 18, 2019
Notice Of Acceptance Of Statement Of Use E-Mailed
Oct 17, 2019
Allowed Principal Register - Sou Accepted
Oct 15, 2019
Statement Of Use Processing Complete
Sep 24, 2019
Use Amendment Filed
Oct 15, 2019
Case Assigned To Intent To Use Paralegal
Sep 24, 2019
Teas Statement Of Use Received
Aug 13, 2019
Noa E-Mailed - Sou Required From Applicant
Jun 18, 2019
Official Gazette Publication Confirmation E-Mailed
Jun 18, 2019
Published For Opposition
May 29, 2019
Notification Of Notice Of Publication E-Mailed
May 13, 2019
Approved For Pub - Principal Register
May 3, 2019
Assigned To Examiner
Apr 23, 2019
Notice Of Design Search Code E-Mailed
Apr 22, 2019
New Application Office Supplied Data Entered
Apr 6, 2019
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
